Compare Cardinal Health Inc (CAH) vs Vanguard Value Index Fund ETF (VTV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Vanguard Value Index Fund ETF — how do they compare? Cardinal Health Inc trades at $230.3 (market cap $54.46B), while Vanguard Value Index Fund ETF trades at $226.57. The key difference: Cardinal Health Inc pays a 0.88% dividend while Vanguard Value Index Fund ETF pays none, and Vanguard Value Index Fund ETF is trading nearer its 52-week high, Cardinal Health Inc nearer its low. Which is the better fit depends on your goals.
| CAH | VTV | |
|---|---|---|
Market Cap | $54.46B | — |
Sector | Health | — |
52-Week High | $240.26 | $226.29 |
52-Week Low | $146.04 | $180.25 |
Enterprise Value | $58.49B | — |
Dividend Yield | 0.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $231.24, down 3.75% on the day, following a strong earnings beat in Q2 2026 with EPS of $2.91 versus $2.42 expected. The stock is in a bullish technical trend with moving averages supporting further upside, while fundamentals show robust revenue growth and improved profitability, with a net income margin of 0.67% for 2025. Recent news highlights record highs post-earnings and optimistic fiscal 2027 guidance.
The outlook for CAH is positive, driven by consistent earnings beats, strong analyst buy ratings (54.55%), and a consensus price target of $270.11 implying significant upside. Key risks include high leverage with a debt-to-asset ratio of 16.09 and reliance on pharmaceutical and specialty business segments for growth amidst competitive pressures.
Vanguard Value ETF (VTV) trades at $226.29, up 0.42% today, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights value stocks outperforming growth in 2026, with VTV up 22% year-to-date. The ETF focuses on large-cap U.S. value stocks, offering diversification with low technology exposure.
The outlook for VTV is positive as value investing gains traction amid AI sector volatility. Opportunities include steady dividends and resilience in market rotations. Risks involve reliance on economic cycles and potential underperformance if growth stocks rebound. Institutional activity shows mixed signals, with some firms increasing stakes while others reduce holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →
